Rani Therapeutics Holdings Inc Cl A (RANI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -28,140 | -14,779 | -67,883 | -53,828 | -35,496 |
| Depreciation Amortization | -11 | -34 | -1,262 | -1,082 | -749 |
| Accounts payable and accrued liabilities | -142 | 158 | -595 | 68 | -332 |
| Other Working Capital | 1,244 | 1,163 | -2,140 | 850 | 1,714 |
| Other Operating Activity | 8,618 | 4,090 | 20,644 | 15,234 | 10,408 |
| Operating Cash Flow | $-18,431 | $-9,402 | $-51,236 | $-38,758 | $-24,455 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 16,931 | 10,312 | 31,089 | 17,648 | 5,495 |
| PPE Investments | -112 | -18 | -1,229 | -1,062 | -583 |
| Investing Cash Flow | $16,819 | $10,294 | $29,860 | $16,586 | $4,912 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 286 | 121 | 395 | 299 | 221 |
| Other Financing Activity | -24 | 0 | -162 | -162 | -133 |
| Financing Cash Flow | $262 | $121 | $233 | $137 | $88 |
| Beginning Cash Position | 6,364 | 6,364 | 27,507 | 27,507 | 27,507 |
| End Cash Position | 5,014 | 7,377 | 6,364 | 5,472 | 8,052 |
| Net Cash Flow | $-1,350 | $1,013 | $-21,143 | $-22,035 | $-19,455 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,431 | -9,402 | -51,236 | -38,758 | -24,455 |
| Capital Expenditure | -112 | -18 | -1,229 | -1,062 | -583 |
| Free Cash Flow | -18,543 | -9,420 | -52,465 | -39,820 | -25,038 |